RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Senderos, Yes, lukewarm. They may not have had much choice other than forking over their own money again since otherwise a default on those notes could have more serious consequences for the company.

Concerning the upcoming Dronabinol results, in the Aug 15 press release they indicated that those results are to be 'published' (see below). If this means in a scientific journal then that's good news since they presumably wouldn't publish lousy results. But we probably shouldn't read too much into it since they might just mean 'released'.

Fwiw, those of us from the Cortex days have come to expect the company to be cursed forever, lol. I mainly just follow it for old time's sake, like a long running soap opera.



>>> A Phase 2B clinical trial evaluating dronabinol in 120 patients with Obstructive Sleep Apnea is being led by University of Illinois researchers. The University of Illinois has indicated that recruitment for this clinical trial was completed during the second quarter of 2016. Final research results are expected to be published in the fourth quarter of 2016 <<<


http://respirerx.com/respirerx-pharmaceuticals-inc-files-june-30-2016-quarterly-report-on-form-10-q/